Anti-Angiotensin Converting Enzyme 1 antibody
5
(2 Reviews)
|
(12 Publications)
Rabbit Polyclonal Angiotensin Converting Enzyme 1 antibody. Suitable for WB, IHC-P and reacts with Human, Recombinant fragment samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human ACE.
View Alternative Names
CD143, DCP, DCP1, ACE, Angiotensin-converting enzyme, Dipeptidyl carboxypeptidase I, Kininase II
- WB
Unknown
Western blot - Anti-Angiotensin Converting Enzyme 1 antibody (AB28311)
Lane 1:
Molecular weight markers
Lanes 2 - 4:
Western blot - Anti-Angiotensin Converting Enzyme 1 antibody (ab28311) at 1/1000 dilution
Lane 2:
rh-ACE-1 at 0.05 µg
Lane 3:
rh-ACE-1 at 0.01 µg
Lane 4:
rh-ACE-1 at 0.001 µg
Predicted band size: 150 kDa
Observed band size: 150 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme generates angiotensin II by cleaving angiotensin I. Angiotensin II an important effector peptide impacts cardiovascular and renal systems influencing vasoconstriction and fluid balance. While not directly forming a complex ACE1's activity increases the potency of angiotensin II which binds to angiotensin II receptors to exert its effects therefore indirectly forming a functional signaling complex.
Pathways
ACE1 plays a central role in the renin-angiotensin system and the kallikrein-kinin system. The enzyme's activity boosts angiotensin II production which connects it to the regulation of blood pressure via the renin-angiotensin pathway. ACE1 also indirectly interacts with proteins like bradykinin by degrading them modulating kinin-related functions and influencing inflammation and tension in vascular smooth muscle.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:1338 PubMed39915484
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37834402
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 73: PubMed37087563
2023
Applications
Unspecified application
Species
Unspecified reactive species
Translational research : the journal of laboratory and clinical medicine 257:43-53 PubMed36736951
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:3698219 PubMed35222797
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of international medical research 48:300060520943453 PubMed32790534
2020
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 177:3691-3711 PubMed32352559
2020
Applications
Unspecified application
Species
Unspecified reactive species
Hypertension research : official journal of the Ja 42:1507-1517 PubMed31138899
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 234:20420-20431 PubMed30989646
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 9:1370 PubMed30364113
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com